Abstract:For the past few years, the predictive role of programmed death-ligand 1 (PD-L1) for anti-PD1 immunotherapy in advance NSCLC has raised People’s attention. Tumor–infiltrating lymphocytes (TILs) are often observed in resected cancer tissue and anticipated in the host adaptive immune response against tumor cells as well. However, expression and the prognostic value of PD-L1 as well as CD8+ TILs in pulmonary neuroendocrine tumors (PNETs) have not been fully studied. The aim of our research is to investigate the status of PD-L1 expression and CD8+ TILs and to measure the prognostic value of PD-L1 and CD8+ TILs in different types of PNETs. Totally 168 specimens of PNETs (36 TC, 7 AC, 100 SCLC, 25 LCNEC) were involved in this study. Immunohistochemistry (IHC) was used to detect the expression of PD-L1 on these cases. Cases demonstrating ≥5% tumor cell expression or any expression (>1%) of PD-L1 on TILs were considered positive. CD8+ TILs both within stroma and tumor areas of invasive carcinoma were analyzed using whole slide digital imaging. For each case, manual regional annotation and machine cell counts were taken. The number of positive cells has been evaluated by counting them in 4 peritumoral and 6 intratumoral non-overlapping fields using the fixed areas of 1.44 square millimeters. PD-L1 was expressed on the membrane of tumor cells or immune cells of 72 cases (42.9%). Significant correlation was observed between CD8+ TILs and PD-L1 expression (P<0.001). For overall survival (OS) and progression free survival (PFS) analysis of PD-L1 as well as CD8+ TILs, there was no association between PD-L1 expression with OS and PFS, however, higher CD8+ TIL levels in stroma was demonstrated to have significant correlations with better OS (P=0.000) and PFS (P=0.020). Importantly, multivariate analysis revealed that CD8+ TILs in stroma was an independent prognostic factor for better OS (p=0.045) and PFS (p=0.006). In high grade NECs, similar analysis was performed and the result showed that positive expression of PD-L1 was associated with better OS (P=0.011) but not with PFS (P=0.383), in contrast, CD8+ TILs in stroma was proved to be an independent prognostic factor for both of OS (p=0.035) and PFS (p=0.005) as well. We found that PD-L1 was expressed in about half of PNETs and correlated with better OS in NECs. Higher CD8+ TIL levels within stroma was positively associated with PD-L1 expression and proved to be an independent prognostic factor for favorable OS and PFS in PNETs and NECs.

Prognostic Value of PD-L1 and PD-1 Expression in Pulmonary Neuroendocrine Tumors.

Prognostic Significance of PD-L1 Expression and CD8+T Cell Infiltration in Pulmonary Neuroendocrine Tumors

P1.07-011 PD-L1 Expression and CD8+ T Cell Infiltration Associate with the Prognosis of Pulmonary Neuroendocrine Tumor

PD-1, PD-L1 Protein Expression in Non-Small Cell Lung Cancer and Their Relationship with Tumor-Infiltrating Lymphocytes

The Clinical Significance of PD-L1/PD-1 Expression in Gastroenteropancreatic Neuroendocrine Neoplasia.

The Predictive And Prognostic Effects Of Pd-L1 Expression On Tki Treatment And Survival Of Egfr-Mutant Nsclc A Meta-Analysis

PD-L1 Expression and Its Effect on Clinical Outcomes of EGFR-mutant NSCLC Patients Treated with EGFR-TKIs

Prognostic Significance of PD-L1 in Advanced Non-Small Cell Lung Carcinoma.

Prognostic Value of Programmed Cell Death Protein 1 Expression on CD8+ T Lymphocytes in Pancreatic Cancer

Prognostic Value of PD-L1 Expression in Combination with CD8+ TILs Density in Patients with Surgically Resected Non-Small Cell Lung Cancer.

The Association Between PD-L1 and EGFR Status and the Prognostic Value of PD-L1 in Advanced Non-Small Cell Lung Cancer Patients Treated with EGFR-TKIs

Prognostic value of PD-L 1 expression in non-small cell lung cancer : a meta-analysis

Prognostic value and immunological role of PD-L1 gene in pan-cancer

PD-1 expression in tumor infiltrating lymphocytes as a prognostic marker in early-stage non-small cell lung cancer

Protein Expression of Programmed Death 1 Ligand 1 and Ligand 2 Independently Predict Poor Prognosis in Surgically Resected Lung Adenocarcinoma

Induction of Patient-Derived Xenograft Formation and Clinical Significance of Programmed Cell Death Ligand 1 (PD-L1) in Lung Cancer Patients.

The clinicopathological and prognostic significance of PD-L1 expression assessed by immunohistochemistry in lung cancer: a meta-analysis of 50 studies with 11,383 patients.

[Expression and Clinical Significance of PD-1 and PD-L1 in Pulmonary Carcinoids].

Association of PD-L 1 expression with clinicopathologic features and overall survival in patients with non-small-cell lung cancer

Prognostic significance of PD-L1 expression and tumor infiltrating lymphocyte in surgically resectable non-small cell lung cancer

PD-L1 Expression and Comprehensive Molecular Profiling Predict Survival in Nonsmall Cell Lung Cancer: A Real-World Study of a Large Chinese Cohort